Look up one drug

Ontario coverage, price, criteria word for word, Health Canada status and shortages for one product

Patient plan: look up a medication list

FRAMYCETIN SULFATE & GRAMICIDIN & DEXAMETHASONE

All products: general benefit

Other products in the same Health Canada class (S03CA) — coverage varies; not interchangeable

  • Betamethasone + gentamicin (Garasone): general benefit

Sofracort · DIN 02224623 · 5mg & 50mcg & 0.5mg/mL · Oph/Ot Sol

General benefitMarketed · checked 2026-09-19
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
No interchangeable product listed in the Ontario extract
Sofracort · DIN 02224623 Manufacturer: Sanofi Aventis Pharma; listing date 2001-10-11 Health Canada: Marketed since 2024-07-30 · brand SOFRACORT · ATC S03CA01 DEXAMETHASONE AND ANTIINFECTIVES · form Drops · route Otic, Ophthalmic · ingredients FRAMYCETIN SULFATE 5 MG/ML, DEXAMETHASONE (DEXAMETHASONE SODIUM METASULPHOBENZOATE) 0.5 MG/ML, GRAMICIDIN 0.05 MG/ML · company Cheplapharm arzneimittel gmbh · schedule Prescription
Check this DIN again · Health Canada product record

Sofracort: Formulary list price $2.2212/unit (unit not stated in source; not the patient's cost)

Ministry pays: $2.2212 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=37363 · Verify on the e-Formulary ↗ (DIN 02224623)

Source record
DIN 02224623: Sofracort Raw flags: sec3=Y Item: 520404012; group id 577; item number 1532; lccId None; manufacturer id SAV Source form: Oph/Ot Sol; strength: 5mg & 50mcg & 0.5mg/mL Recorded listing: General benefit Source prices (unrounded): $2.2212; ministry $2.2212 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02224623 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=37363 Therapeutic Notes (formulary) The risk of ototoxicity with topical aminoglycoside may increase with prolonged therapy. Topical use of antibiotics increases the likelihood of development of bacterial resistance, especially with prolonged use, sometimes rendering the systemic use of this antibiotic class useless in these patients.
Shortage status: not checked (no credentials)
Other drugs in the same formulary class (52:04:04 Antibiotics) and how they are covered

Matched class: 52:04:04 Antibiotics

Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment. Covered without a code on the Ontario formulary: FRAMYCETIN SULFATE, GENTAMICIN & BETAMETHASONE SODIUM PHOSPHATE, GENTAMICIN SULFATE, POLYMYXIN B SULFATE & BACITRACIN (ZINC), POLYMYXIN B SULFATE & GRAMICIDIN, TOBRAMYCIN, TOBRAMYCIN & DEXAMETHASONE 52:04:04 Antibiotics

GENTAMICIN & BETAMETHASONE SODIUM PHOSPHATE

· 1 products · General benefit · strengths: 3mg & 1mg/mL · Oph/Ot Drops

FRAMYCETIN SULFATE

· 2 products · General benefit · strengths: 0.5% · Oph Oint-5g Pk, Oph Sol

GENTAMICIN SULFATE

· 1 products · General benefit · strengths: 0.3% · Oph Oint-3.5g Pk

POLYMYXIN B SULFATE & BACITRACIN (ZINC)

· 1 products · General benefit · strengths: 10000U & 500U/g · Oph Oint 3.5g Pk

POLYMYXIN B SULFATE & GRAMICIDIN

· 1 products · General benefit · strengths: 10000U & 0.025mg/mL · Oph/Ot Sol

TOBRAMYCIN

· 3 products · General benefit · strengths: 0.3% · Oph Oint, Oph Sol

TOBRAMYCIN & DEXAMETHASONE

· 2 products · General benefit · strengths: 0.3% & 0.1% · Oph Oint, Oph Susp

CIPROFLOXACIN AND DEXAMETHASONE

· 3 products · Limited Use, codes 509 · strengths: 0.3% w/v & 0.1% w/v · Otic Susp-7.5mL Pk (With Preservative)

GATIFLOXACIN

· 3 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 0.3% w/v · Oph Sol

MOXIFLOXACIN HYDROCHLORIDE

· 8 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 0.5% · Oph Sol-3mL Pk (Preservative-Free) Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26; class 52:04:04
Full class listing Related classes: 52:04:12 Other Anti-Infectives, 52:08:92 Anti-Inflammatory Agents, Miscellaneous Same formulary class, not same indication: class membership alone does not establish equivalent uses.
What the Health Canada label says it is for
1 INDICATIONS SOFRACORT (framycetin sulfate, dexamethasone and gramicidin ophthalmic/otic solution) is indicated for: • Eye: Blepharitis and infected eczema of the eyelid; allergic, infective and rosacea conjunctivitis; rosacea keratitis; scleritis and episcleritis; iridocyclitis, and other inflammatory conditions of the anterior segment of the eye. • Ear: Otitis externa (acute and chronic) and other inflammatory and seborrheic conditions of the external ear. SOFRACORT contains antibacterial ingredients, framycetin and gramicidin. To reduce the development of drug-resistant bacteria and maintain the effectiveness of framycetin and gramicidin, SOFRACORT should only be used for the authorized indication. 1.1 Pediatrics Pediatrics (< 18 years of age): No data are available to Health Canada; therefore, Health Canada has not authorized an indication for pediatric use (see 7.1.3 Pediatrics). 1.2 Geriatrics Geriatrics: No data are available to Health Canada; therefore, Health Canada has not authorized an indication for geriatric use. https://pdf.hres.ca/dpd_pm/00076258.PDF PM date: not printed or not captured Source product: SOFRACORT; DIN 02224623; fetched 2026-09-10 Product monograph posted by Health Canada; excerpt for lookup only.